why choose us

First received: January 31, 2023

Clinical Trial: A Phase 1, Randomized, Placebo-Controlled Safety and Tolerability Study Of Intravenous SBS-1000 in Healthy Adults

Study Status: Completed

Recruit Status: RECRUITING

Condition: Pain

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of SBS-1000 Administered by Intraven

Brief Summary: This study will be a single-center, double-blind, randomized placebo-controlled, adaptive, single ascending dose study.

Read more